← Open Payments lookup

RHODA OLATAYO: Open Payments

NPI 1821706912 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,560 in 69 payments from 13 companies in 2025. Trend: 2023 $970 · 2024 $1,733 · 2025 $1,560

Food & beverage: $1,560
CompanyPaymentsAmount
ABBVIE INC.36$716
Takeda Pharmaceuticals U.S.A., Inc.8$222
Madrigal Pharmaceuticals4$110
Janssen Biotech, Inc.4$107
GENZYME CORPORATION3$104
Aimmune Therapeutics, Inc.3$74
Celltrion USA Inc.3$54
Phathom Pharmaceuticals, Inc.2$46
EVOKE PHARMA, INC.2$36
Ipsen Biopharmaceuticals, Inc1$30

Products named: SKYRIZI, ENTYVIO, RINVOQ, CREON, LINZESS, REZDIFFRA, TREMFYA, DUPIXENT.

Industry payments across TX — which companies pay providers there.